chr1-246849956-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001323342.2(AHCTF1):c.6050G>T(p.Ser2017Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001323342.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AHCTF1 | NM_001323342.2 | c.6050G>T | p.Ser2017Ile | missense_variant | 33/36 | ENST00000648844.2 | NP_001310271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AHCTF1 | ENST00000648844.2 | c.6050G>T | p.Ser2017Ile | missense_variant | 33/36 | NM_001323342.2 | ENSP00000497061 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000877 AC: 22AN: 250720Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135622
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461636Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727124
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.6077G>T (p.S2026I) alteration is located in exon 33 (coding exon 33) of the AHCTF1 gene. This alteration results from a G to T substitution at nucleotide position 6077, causing the serine (S) at amino acid position 2026 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at